Job offer in london Research Associate in Neurodegeneration at University College London
University College London – Ocular Biology and Therapeutics
Per annum, inclusive of London Allowance
|Placed on:||10th May 2017|
|Closes:||24th May 2017|
UCL Institute of Ophthalmology
The appointment will be on UCL Grade 7.
Applicants are invited for a Research Associate position in a research programme in neurodegeneration caused by mutations in rhodopsin. The post is funded by a Wellcome Trust Investigator award for 5 years in the first instance, and is available from June 1 2017. The aims of the research are to use patient derived stem cells and CRISPR produced knock-in rodent models to understand the mechanisms of retinal degeneration caused by mutations in rhodopsin and develop potential therapies.
Molecular biology and cell biology experience. Experience with stem cell and/or cell models of disease. Applicants must have a PhD in a suitable area. Previous experience, or a good understanding, of vision, stem cell biology, and rodent physiology is strongly recommended, though individuals without direct experience in these areas, but with exceptional motivation or experience of research in related areas, are also encouraged to apply.
A job description and person specification can be accessed at the bottom of this page.
UCL vacancy reference: 1643725
Applicants should apply online. To access further details about the position and how to apply please click on the ‘Apply’ button below.
Please ensure you attach your CV and list of publications. You should also provide a personal statement to support your application. Please email informal queries to Professor Mike Cheetham Michael.firstname.lastname@example.org If you have any enquiries regarding the application process please email: email@example.com
Latest time for the submission of applications: 23:59.
Interview Date: TBC
UCL Taking Action for Equality
Share this job
If you have a comment to make about the overall quality of this advert,
or its categorisation then please
send us your feedback